Table II.
Pulmonary Hypertension Treatment of the 3 Groups
| Medications | Normal | PH-C | PH-D | P Value |
|---|---|---|---|---|
| No. | 10 | 20 | 26 | |
| No. of patients treated | 3a | 8 | 13 | NS |
| Monotherapy | 3a | 4 | 10 | NS |
| Combination of 2 medications | 0 | 4 | 2 | NS |
| Combination of 3 medications | 0 | 0 | 1 | NS |
| Sildenafil | 0 | 1 | 4 | NS |
| Prostacyclins | 0 | 3 | 4 | NS |
| Endothelin receptor antagonist | 0 | 4 | 5 | NS |
| Calcium channel blocker | 3 | 4 | 6 | NS |
Abbreviations: NS, not significant; PH-C, pulmonary hypertension and hemodynamically compensated right ventricular function; PH-D, pulmonary hypertension and hemodynamically decompensated right ventricular function.
a
Not being used for the indication of pulmonary hypertension.